- Report
- September 2025
- 50 Pages
Global
From €2331EUR$2,650USD£2,023GBP
- Report
- September 2025
- 56 Pages
Germany
From €1188EUR$1,350USD£1,030GBP
- Report
- September 2025
- 70 Pages
South Korea
From €1188EUR$1,350USD£1,030GBP
- Report
- September 2025
- 70 Pages
United States
From €1188EUR$1,350USD£1,030GBP
From €1188EUR$1,350USD£1,030GBP
- Report
- September 2025
- 47 Pages
Thailand
From €1188EUR$1,350USD£1,030GBP
- Report
- September 2025
- 70 Pages
Switzerland
From €1188EUR$1,350USD£1,030GBP
- Report
- September 2025
- 70 Pages
Sweden
From €1188EUR$1,350USD£1,030GBP
- Report
- September 2025
- 70 Pages
Spain
From €1188EUR$1,350USD£1,030GBP
- Report
- September 2025
- 70 Pages
South Korea
From €1188EUR$1,350USD£1,030GBP
- Report
- September 2025
- 70 Pages
Singapore
From €1188EUR$1,350USD£1,030GBP
- Report
- September 2025
- 70 Pages
Russia
From €1188EUR$1,350USD£1,030GBP
- Report
- September 2025
- 70 Pages
Netherlands
From €1188EUR$1,350USD£1,030GBP
- Report
- September 2025
- 70 Pages
Japan
From €1188EUR$1,350USD£1,030GBP
- Report
- September 2025
- 70 Pages
Italy
From €1188EUR$1,350USD£1,030GBP
- Report
- September 2025
- 70 Pages
China
From €1188EUR$1,350USD£1,030GBP
- Report
- September 2025
- 70 Pages
Brazil
From €1188EUR$1,350USD£1,030GBP
- Report
- September 2025
- 50 Pages
Global
From €2331EUR$2,650USD£2,023GBP
- Report
- April 2025
- 211 Pages
China
From €3519EUR$4,000USD£3,053GBP

The Gastrointestinal Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat diseases and disorders of the gastrointestinal tract. These drugs are used to treat conditions such as irritable bowel syndrome, Crohn's disease, ulcerative colitis, and gastroesophageal reflux disease. Commonly prescribed drugs include antacids, proton pump inhibitors, and H2 receptor antagonists.
The Gastrointestinal Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Pfizer, GlaxoSmithKline, Merck & Co., AstraZeneca, and Novartis. These companies are constantly developing new drugs and treatments to meet the needs of patients. Show Less Read more